STAT Plus: Definium’s LSD therapy eased anxiety in second large trial
Definium is among a wave of biotechs nearing regulatory approval for psychedelic therapies, which appear to exert rapid benefits for patients.
Open original source
Definium is among a wave of biotechs nearing regulatory approval for psychedelic therapies, which appear to exert rapid benefits for patients.
Open original sourceComments stay attached to this story.
Start a connected post from this article without changing the original story.
Creators building their communities through the SpiderTaz Creator Program.
No comments yet.